
Blueprint Medicines Corporation BPMC
Quartalsbericht 2025-Q1
hinzugefügt 01.05.2025
Blueprint Medicines Corporation PEG 2011-2026 | BPMC
PEG Jährlich Blueprint Medicines Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -120 | -37.8 | -0.516 | -2.75 | 5.15 | 0.253 | 0.35 | 0.426 | -0.899 | 0.285 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.15 | -120 | -15.5 |
PEG anderer Aktien in der Pharmaeinzelhändler
| Name | PEG | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Burford Capital Limited
BUR
|
-0.568 | $ 4.74 | 0.53 % | $ 761 M | ||
|
Cabaletta Bio
CABA
|
-0.01 | $ 3.33 | 2.15 % | $ 335 M | ||
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 3.07 | 0.49 % | $ 5.05 M | ||
|
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
-0.955 | $ 332.58 | -2.01 % | $ 43.6 B | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.0509 | $ 3.8 | 4.97 % | $ 9.14 B | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B | ||
|
Aligos Therapeutics
ALGS
|
0.0282 | $ 7.51 | -14.07 % | $ 74.2 M | ||
|
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | ||
|
Esperion Therapeutics
ESPR
|
0.799 | $ 2.11 | 2.77 % | $ 439 M | ||
|
Evogene Ltd.
EVGN
|
-1.63 | $ 0.82 | - | $ 27.9 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
Forte Biosciences
FBRX
|
0.00783 | $ 32.35 | -0.2 % | $ 419 M | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
0.0342 | - | -13.39 % | $ 1.45 M | ||
|
Galapagos NV
GLPG
|
0.0003 | $ 28.99 | 0.36 % | $ 2.69 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 21.36 | -0.09 % | $ 998 M | ||
|
Genmab A/S
GMAB
|
0.277 | $ 29.02 | -0.14 % | $ 18.6 B | ||
|
GT Biopharma
GTBP
|
-0.00067 | $ 0.38 | -3.34 % | $ 2.1 M | ||
|
BioNTech SE
BNTX
|
-12.8 | $ 99.43 | 1.03 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | ||
|
Hoth Therapeutics
HOTH
|
-0.00188 | $ 0.68 | 4.58 % | $ 9.39 M | ||
|
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | ||
|
Harmony Biosciences Holdings
HRMY
|
0.631 | $ 29.37 | 0.27 % | $ 1.69 B | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
ImmuCell Corporation
ICCC
|
0.153 | $ 7.61 | -1.55 % | $ 68.7 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
1.02 | $ 1.54 | -1.28 % | $ 396 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
-0.64 | $ 4.18 | 0.6 % | $ 447 M | ||
|
Arcutis Biotherapeutics
ARQT
|
0.0316 | $ 24.39 | -2.79 % | $ 3.1 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.00304 | - | -2.5 % | $ 5.88 M | ||
|
Immatics N.V.
IMTX
|
2.14 K | $ 10.9 | -0.46 % | $ 686 M | ||
|
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | ||
|
Incyte Corporation
INCY
|
0.135 | $ 97.43 | -0.27 % | $ 19 B | ||
|
BioDelivery Sciences International
BDSI
|
0.69 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.46 | -1.49 % | $ 389 M | ||
|
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | ||
|
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B | ||
|
Innate Pharma S.A.
IPHA
|
-0.0174 | $ 1.71 | 4.91 % | $ 235 M |